_id
6914804eccc777a4e85d9294
Ticker
NCNA
Name
NuCana PLC
Exchange
NASDAQ
Address
3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.nucana.com
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer; Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer; and Phase 1 modular clinical trial for patients with advanced solid tumors and lung cancer. The company is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is based in Edinburgh, the United Kingdom.
Last Close
4.05
Volume
38380
Current Price
3.72
Change
-8.14814814814814
Last Updated
2025-12-02T12:24:04.722Z
Image
-
Ipo Date
2017-09-28T00:00:00.000Z
Market Cap
7632316
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.981
Sentiment Sources
2
Rating
3
Target Price
104
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
779000
Operating Income
-779000
Interest Expense
-
Pretax Income
-626000
Net Income
-281000
Eps
-0.07601030818798729
Dividends Per Share
-
Shares Outstanding
1908078
Income Tax Expense
-345000
EBITDA
-3502000
Operating Margin
-
Total Other Income Expense Net
153000
Cash
25249000
Short Term Investments
-
Receivables
4589000
Inventories
-
Total Current Assets
29838000
Property Plant Equipment
157000
Total Assets
32315000
Payables
1662000
Short Term Debt
76000
Long Term Debt
-
Total Liabilities
6389000
Equity
25926000
Depreciation
69000
Change In Working Capital
-1733000
Cash From Operations
1278000
Capital Expenditures
47000
Cash From Investing
64000
Cash From Financing
15238000
Net Change In Cash
16806000
PE
0.0101
PB
0.5304460865540385
ROE
-1.0838540461312967
ROA
-0.8695652173913043
FCF
1231000
Fcf Percent
-
Piotroski FScore
2
Health Score
43
Deep Value Investing Score
10
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
9.5
Quality Investing Score
4.5
Value Investing Score
8
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
779000
Quarters > 0 > income Statement > operating Income
-779000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-626000
Quarters > 0 > income Statement > net Income
-281000
Quarters > 0 > income Statement > eps
-0.07601030818798729
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3696867
Quarters > 0 > income Statement > income Tax Expense
-345000
Quarters > 0 > income Statement > EBITDA
-3502000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
153000
Quarters > 0 > balance Sheet > cash
25249000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4589000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
29838000
Quarters > 0 > balance Sheet > property Plant Equipment
157000
Quarters > 0 > balance Sheet > total Assets
32315000
Quarters > 0 > balance Sheet > payables
1662000
Quarters > 0 > balance Sheet > short Term Debt
76000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6389000
Quarters > 0 > balance Sheet > equity
25926000
Quarters > 0 > cash Flow > net Income
-281000
Quarters > 0 > cash Flow > depreciation
69000
Quarters > 0 > cash Flow > change In Working Capital
-1733000
Quarters > 0 > cash Flow > cash From Operations
1278000
Quarters > 0 > cash Flow > capital Expenditures
47000
Quarters > 0 > cash Flow > cash From Investing
64000
Quarters > 0 > cash Flow > cash From Financing
15238000
Quarters > 0 > cash Flow > net Change In Cash
16806000
Quarters > 0 > ratios > PE
-0.07601030818798729
Quarters > 0 > ratios > PB
0.5304460865540385
Quarters > 0 > ratios > ROE
-1.0838540461312967
Quarters > 0 > ratios > ROA
-0.8695652173913043
Quarters > 0 > ratios > FCF
1231000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
11829000
Quarters > 1 > income Statement > operating Income
-11829000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-24442000
Quarters > 1 > income Statement > net Income
-24114000
Quarters > 1 > income Statement > eps
-3.971291550835957
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6072080
Quarters > 1 > income Statement > income Tax Expense
-328000
Quarters > 1 > income Statement > EBITDA
-11558000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-12613000
Quarters > 1 > balance Sheet > cash
8443000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
5286000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13729000
Quarters > 1 > balance Sheet > property Plant Equipment
178000
Quarters > 1 > balance Sheet > total Assets
16218000
Quarters > 1 > balance Sheet > payables
1098000
Quarters > 1 > balance Sheet > short Term Debt
75000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8834000
Quarters > 1 > balance Sheet > equity
7384000
Quarters > 1 > cash Flow > net Income
-24114000
Quarters > 1 > cash Flow > depreciation
69000
Quarters > 1 > cash Flow > change In Working Capital
-963000
Quarters > 1 > cash Flow > cash From Operations
-4486000
Quarters > 1 > cash Flow > capital Expenditures
57000
Quarters > 1 > cash Flow > cash From Investing
-28000
Quarters > 1 > cash Flow > cash From Financing
9319000
Quarters > 1 > cash Flow > net Change In Cash
4490000
Quarters > 1 > ratios > PE
-3.971291550835957
Quarters > 1 > ratios > PB
3.0590652221018417
Quarters > 1 > ratios > ROE
-326.5709642470206
Quarters > 1 > ratios > ROA
-148.6866444691084
Quarters > 1 > ratios > FCF
-4543000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2851000
Quarters > 2 > income Statement > operating Income
-2851000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2826000
Quarters > 2 > income Statement > net Income
-2473000
Quarters > 2 > income Statement > eps
-0.40727394895982927
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6072080
Quarters > 2 > income Statement > income Tax Expense
-353000
Quarters > 2 > income Statement > EBITDA
-2725000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
25000
Quarters > 2 > balance Sheet > cash
3953000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5164000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
9117000
Quarters > 2 > balance Sheet > property Plant Equipment
177000
Quarters > 2 > balance Sheet > total Assets
11601000
Quarters > 2 > balance Sheet > payables
2403000
Quarters > 2 > balance Sheet > short Term Debt
74000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7427000
Quarters > 2 > balance Sheet > equity
4174000
Quarters > 2 > cash Flow > net Income
-2473000
Quarters > 2 > cash Flow > depreciation
67000
Quarters > 2 > cash Flow > change In Working Capital
-1686000
Quarters > 2 > cash Flow > cash From Operations
-3109000
Quarters > 2 > cash Flow > capital Expenditures
39000
Quarters > 2 > cash Flow > cash From Investing
-11000
Quarters > 2 > cash Flow > cash From Financing
442000
Quarters > 2 > cash Flow > net Change In Cash
-2796000
Quarters > 2 > ratios > PE
-0.40727394895982927
Quarters > 2 > ratios > PB
5.41162855773838
Quarters > 2 > ratios > ROE
-59.24772400574988
Quarters > 2 > ratios > ROA
-21.31712783380743
Quarters > 2 > ratios > FCF
-3148000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
865000
Quarters > 3 > income Statement > operating Income
-865000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-790000
Quarters > 3 > income Statement > net Income
-653000
Quarters > 3 > income Statement > eps
-0.11534072232259829
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5661487
Quarters > 3 > income Statement > income Tax Expense
-137000
Quarters > 3 > income Statement > EBITDA
-1154000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
75000
Quarters > 3 > balance Sheet > cash
6749000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4639000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
12265000
Quarters > 3 > balance Sheet > property Plant Equipment
197000
Quarters > 3 > balance Sheet > total Assets
14774000
Quarters > 3 > balance Sheet > payables
2705000
Quarters > 3 > balance Sheet > short Term Debt
73000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
8820000
Quarters > 3 > balance Sheet > equity
5954000
Quarters > 3 > cash Flow > net Income
-653000
Quarters > 3 > cash Flow > depreciation
115000
Quarters > 3 > cash Flow > change In Working Capital
-6117000
Quarters > 3 > cash Flow > cash From Operations
-7455000
Quarters > 3 > cash Flow > capital Expenditures
51000
Quarters > 3 > cash Flow > cash From Investing
22000
Quarters > 3 > cash Flow > cash From Financing
2185000
Quarters > 3 > cash Flow > net Change In Cash
-4602000
Quarters > 3 > ratios > PE
-0.11534072232259829
Quarters > 3 > ratios > PB
3.537240786026201
Quarters > 3 > ratios > ROE
-10.96741686261337
Quarters > 3 > ratios > ROA
-4.419926898605659
Quarters > 3 > ratios > FCF
-7506000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
22904000
Annuals > 0 > income Statement > operating Income
-22809000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-22451000
Annuals > 0 > income Statement > net Income
-18997000
Annuals > 0 > income Statement > eps
-3.200691458532706
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5935280
Annuals > 0 > income Statement > income Tax Expense
-3454000
Annuals > 0 > income Statement > EBITDA
-22483000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
358000
Annuals > 0 > balance Sheet > cash
6749000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4639000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
12265000
Annuals > 0 > balance Sheet > property Plant Equipment
197000
Annuals > 0 > balance Sheet > total Assets
14774000
Annuals > 0 > balance Sheet > payables
2705000
Annuals > 0 > balance Sheet > short Term Debt
73000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8820000
Annuals > 0 > balance Sheet > equity
5954000
Annuals > 0 > cash Flow > net Income
-18997000
Annuals > 0 > cash Flow > depreciation
522000
Annuals > 0 > cash Flow > change In Working Capital
-2183000
Annuals > 0 > cash Flow > cash From Operations
-19118000
Annuals > 0 > cash Flow > capital Expenditures
293000
Annuals > 0 > cash Flow > cash From Investing
79000
Annuals > 0 > cash Flow > cash From Financing
8184000
Annuals > 0 > cash Flow > net Change In Cash
-10476000
Annuals > 0 > ratios > PE
-3.200691458532706
Annuals > 0 > ratios > PB
3.987423580786026
Annuals > 0 > ratios > ROE
-319.0628149143433
Annuals > 0 > ratios > ROA
-128.58399891701637
Annuals > 0 > ratios > FCF
-19411000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
20
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
31125000
Annuals > 1 > income Statement > operating Income
-32784000
Annuals > 1 > income Statement > interest Expense
1103000
Annuals > 1 > income Statement > pretax Income
-32030000
Annuals > 1 > income Statement > net Income
-27632000
Annuals > 1 > income Statement > eps
-5.245752254390128
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5267500
Annuals > 1 > income Statement > income Tax Expense
-4398000
Annuals > 1 > income Statement > EBITDA
-31783000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
754000
Annuals > 1 > balance Sheet > cash
17225000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
5825000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
25019000
Annuals > 1 > balance Sheet > property Plant Equipment
521000
Annuals > 1 > balance Sheet > total Assets
27811000
Annuals > 1 > balance Sheet > payables
3375000
Annuals > 1 > balance Sheet > short Term Debt
206000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
12924000
Annuals > 1 > balance Sheet > equity
14887000
Annuals > 1 > cash Flow > net Income
-27632000
Annuals > 1 > cash Flow > depreciation
575000
Annuals > 1 > cash Flow > change In Working Capital
-1281000
Annuals > 1 > cash Flow > cash From Operations
-26439000
Annuals > 1 > cash Flow > capital Expenditures
478000
Annuals > 1 > cash Flow > cash From Investing
2888000
Annuals > 1 > cash Flow > cash From Financing
-53000
Annuals > 1 > cash Flow > net Change In Cash
-24687000
Annuals > 1 > ratios > PE
-5.245752254390128
Annuals > 1 > ratios > PB
1.4153288103714652
Annuals > 1 > ratios > ROE
-185.61160744273528
Annuals > 1 > ratios > ROA
-99.35636978174104
Annuals > 1 > ratios > FCF
-26917000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
43717000
Annuals > 2 > income Statement > operating Income
-43696000
Annuals > 2 > income Statement > interest Expense
9859000
Annuals > 2 > income Statement > pretax Income
-38453000
Annuals > 2 > income Statement > net Income
-32021000
Annuals > 2 > income Statement > eps
-6.131354715174725
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
5222500
Annuals > 2 > income Statement > income Tax Expense
-6432000
Annuals > 2 > income Statement > EBITDA
-52154000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5243000
Annuals > 2 > balance Sheet > cash
41912000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
50000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
54920000
Annuals > 2 > balance Sheet > property Plant Equipment
866000
Annuals > 2 > balance Sheet > total Assets
58254000
Annuals > 2 > balance Sheet > payables
4803000
Annuals > 2 > balance Sheet > short Term Debt
486000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
19752000
Annuals > 2 > balance Sheet > equity
38502000
Annuals > 2 > cash Flow > net Income
-32021000
Annuals > 2 > cash Flow > depreciation
732000
Annuals > 2 > cash Flow > change In Working Capital
3723000
Annuals > 2 > cash Flow > cash From Operations
-23158000
Annuals > 2 > cash Flow > capital Expenditures
518000
Annuals > 2 > cash Flow > cash From Investing
120000
Annuals > 2 > cash Flow > cash From Financing
-161000
Annuals > 2 > cash Flow > net Change In Cash
-18352000
Annuals > 2 > ratios > PE
-6.131354715174725
Annuals > 2 > ratios > PB
0.5425692171835229
Annuals > 2 > ratios > ROE
-83.16710820217132
Annuals > 2 > ratios > ROA
-54.96789920005494
Annuals > 2 > ratios > FCF
-23676000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
45363000
Annuals > 3 > income Statement > operating Income
-45345000
Annuals > 3 > income Statement > interest Expense
4981000
Annuals > 3 > income Statement > pretax Income
-47802000
Annuals > 3 > income Statement > net Income
-40533000
Annuals > 3 > income Statement > eps
-9.735833285294287
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4163280
Annuals > 3 > income Statement > income Tax Expense
-7269000
Annuals > 3 > income Statement > EBITDA
-41879000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-2457000
Annuals > 3 > balance Sheet > cash
60264000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
11349000
Annuals > 3 > balance Sheet > inventories
-11349
Annuals > 3 > balance Sheet > total Current Assets
71613000
Annuals > 3 > balance Sheet > property Plant Equipment
851000
Annuals > 3 > balance Sheet > total Assets
77474000
Annuals > 3 > balance Sheet > payables
1829000
Annuals > 3 > balance Sheet > short Term Debt
414000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
11926000
Annuals > 3 > balance Sheet > equity
65548000
Annuals > 3 > cash Flow > net Income
-40533000
Annuals > 3 > cash Flow > depreciation
942000
Annuals > 3 > cash Flow > change In Working Capital
4095000
Annuals > 3 > cash Flow > cash From Operations
-23824000
Annuals > 3 > cash Flow > capital Expenditures
1065000
Annuals > 3 > cash Flow > cash From Investing
-3561000
Annuals > 3 > cash Flow > cash From Financing
-98000
Annuals > 3 > cash Flow > net Change In Cash
-27092000
Annuals > 3 > ratios > PE
-9.735833285294287
Annuals > 3 > ratios > PB
0.25405992555074147
Annuals > 3 > ratios > ROE
-61.83712699090743
Annuals > 3 > ratios > ROA
-52.31819707256628
Annuals > 3 > ratios > FCF
-24889000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
0.0101
Valuation > metrics > PB
0.5304460865540385
Valuation > final Score
90
Valuation > verdict
73.4% Undervalued
Profitability > metrics > ROE
-1.0838540461312967
Profitability > metrics > ROA
-0.9417521281587238
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.24643215305099128
Risk > metrics > Interest Coverage
-0.27086230876216966
Risk > final Score
59
Risk > verdict
High
Liquidity > metrics > Current Ratio
17.16800920598389
Liquidity > metrics > Quick Ratio
17.16800920598389
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
49.409347778981584
Prev Valuations > 1
25.883714422616197
Prev Valuations > 2
44.627592139737985
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
26
Prev Risks > 1
-83
Prev Risks > 2
20
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:53:49.377Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-08-20
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-23.31
Earnings History > 0 > eps Estimate
-13
Earnings History > 0 > eps Difference
-10.31
Earnings History > 0 > surprise Percent
-79.3077
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-14
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
GBP
Earnings History > 1 > eps Actual
-0.5129
Earnings History > 1 > eps Estimate
-13
Earnings History > 1 > eps Difference
12.4871
Earnings History > 1 > surprise Percent
96.0546
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-20
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-64.85
Earnings History > 2 > eps Estimate
-440
Earnings History > 2 > eps Difference
375.15
Earnings History > 2 > surprise Percent
85.2614
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-25
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-439.6
Earnings History > 3 > eps Estimate
-790
Earnings History > 3 > eps Difference
350.4
Earnings History > 3 > surprise Percent
44.3544
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-08-15
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-300
Earnings History > 4 > eps Estimate
-180.85
Earnings History > 4 > eps Difference
-119.15
Earnings History > 4 > surprise Percent
-65.8833
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-16
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-3.25
Earnings History > 5 > eps Estimate
-276.55
Earnings History > 5 > eps Difference
273.3
Earnings History > 5 > surprise Percent
98.8248
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2024-03-20
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-350
Earnings History > 6 > eps Estimate
-254.95
Earnings History > 6 > eps Difference
-95.05
Earnings History > 6 > surprise Percent
-37.2818
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-11-16
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-13
Earnings History > 7 > eps Estimate
-10.07
Earnings History > 7 > eps Difference
-2.93
Earnings History > 7 > surprise Percent
-29.0963
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-08-16
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-10
Earnings History > 8 > eps Estimate
-12.79
Earnings History > 8 > eps Difference
2.79
Earnings History > 8 > surprise Percent
21.8139
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-05-17
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-15
Earnings History > 9 > eps Estimate
-11
Earnings History > 9 > eps Difference
-4
Earnings History > 9 > surprise Percent
-36.3636
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2023-03-22
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.0012
Earnings History > 10 > eps Estimate
-0.0012
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-16
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-9
Earnings History > 11 > eps Estimate
-11.64
Earnings History > 11 > eps Difference
2.64
Earnings History > 11 > surprise Percent
22.6804
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-08-17
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-7
Earnings History > 12 > eps Estimate
-12.18
Earnings History > 12 > eps Difference
5.18
Earnings History > 12 > surprise Percent
42.5287
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-06-02
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-16
Earnings History > 13 > eps Estimate
-16.51
Earnings History > 13 > eps Difference
0.51
Earnings History > 13 > surprise Percent
3.089
Earnings History > 14 > period
2021-12-31
Earnings History > 14 > report Date
2021-12-31
Earnings History > 14 > date
2021-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-21
Earnings History > 14 > eps Estimate
-19.81
Earnings History > 14 > eps Difference
-1.19
Earnings History > 14 > surprise Percent
-6.0071
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-11-18
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-15
Earnings History > 15 > eps Estimate
-18.5
Earnings History > 15 > eps Difference
3.5
Earnings History > 15 > surprise Percent
18.9189
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-08-19
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-17
Earnings History > 16 > eps Estimate
-19.27
Earnings History > 16 > eps Difference
2.27
Earnings History > 16 > surprise Percent
11.78
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-05-19
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-19
Earnings History > 17 > eps Estimate
-16.86
Earnings History > 17 > eps Difference
-2.14
Earnings History > 17 > surprise Percent
-12.6928
Earnings History > 18 > period
2020-12-31
Earnings History > 18 > report Date
2021-03-04
Earnings History > 18 > date
2020-12-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
-24
Earnings History > 18 > eps Estimate
-16.11
Earnings History > 18 > eps Difference
-7.89
Earnings History > 18 > surprise Percent
-48.9758
Earnings History > 19 > period
2020-09-30
Earnings History > 19 > report Date
2020-11-19
Earnings History > 19 > date
2020-09-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
-24
Earnings History > 19 > eps Estimate
-18.8
Earnings History > 19 > eps Difference
-5.2
Earnings History > 19 > surprise Percent
-27.6596
Earnings History > 20 > period
2020-06-30
Earnings History > 20 > report Date
2020-08-19
Earnings History > 20 > date
2020-06-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
-19
Earnings History > 20 > eps Estimate
-18.17
Earnings History > 20 > eps Difference
-0.83
Earnings History > 20 > surprise Percent
-4.568
Earnings History > 21 > period
2020-03-31
Earnings History > 21 > report Date
2020-05-19
Earnings History > 21 > date
2020-03-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
-12
Earnings History > 21 > eps Estimate
-18.2
Earnings History > 21 > eps Difference
6.2
Earnings History > 21 > surprise Percent
34.0659
Earnings History > 22 > period
2019-12-31
Earnings History > 22 > report Date
2020-03-10
Earnings History > 22 > date
2019-12-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
-24
Earnings History > 22 > eps Estimate
-16.2
Earnings History > 22 > eps Difference
-7.8
Earnings History > 22 > surprise Percent
-48.1481
Earnings History > 23 > period
2019-09-30
Earnings History > 23 > report Date
2019-11-13
Earnings History > 23 > date
2019-09-30
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
GBP
Earnings History > 23 > eps Actual
-12
Earnings History > 23 > eps Estimate
-22.8
Earnings History > 23 > eps Difference
10.8
Earnings History > 23 > surprise Percent
47.3684
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-08-21
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
GBP
Earnings History > 24 > eps Actual
-14
Earnings History > 24 > eps Estimate
-19.2
Earnings History > 24 > eps Difference
5.2
Earnings History > 24 > surprise Percent
27.0833
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-05-14
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
GBP
Earnings History > 25 > eps Actual
-17
Earnings History > 25 > eps Estimate
-20.9
Earnings History > 25 > eps Difference
3.9
Earnings History > 25 > surprise Percent
18.6603
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-03-07
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
GBP
Earnings History > 26 > eps Actual
-11
Earnings History > 26 > eps Estimate
-19.05
Earnings History > 26 > eps Difference
8.05
Earnings History > 26 > surprise Percent
42.2572
Earnings History > 27 > period
2018-09-30
Earnings History > 27 > report Date
2018-11-27
Earnings History > 27 > date
2018-09-30
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
GBP
Earnings History > 27 > eps Actual
-8
Earnings History > 27 > eps Estimate
-21.52
Earnings History > 27 > eps Difference
13.52
Earnings History > 27 > surprise Percent
62.8253
Earnings History > 28 > period
2018-06-30
Earnings History > 28 > report Date
2018-08-28
Earnings History > 28 > date
2018-06-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
GBP
Earnings History > 28 > eps Actual
-4
Earnings History > 28 > eps Estimate
-19.67
Earnings History > 28 > eps Difference
15.67
Earnings History > 28 > surprise Percent
79.6645
Earnings History > 29 > period
2018-03-31
Earnings History > 29 > report Date
2018-05-23
Earnings History > 29 > date
2018-03-31
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
GBP
Earnings History > 29 > eps Actual
-20
Earnings History > 29 > eps Estimate
-15.5
Earnings History > 29 > eps Difference
-4.5
Earnings History > 29 > surprise Percent
-29.0323
Earnings History > 30 > period
2017-12-31
Earnings History > 30 > report Date
2018-03-21
Earnings History > 30 > date
2017-12-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
GBP
Earnings History > 30 > eps Actual
-0.73
Earnings History > 30 > eps Estimate
-8.9
Earnings History > 30 > eps Difference
8.17
Earnings History > 30 > surprise Percent
91.7978
Earnings History > 31 > period
2017-09-30
Earnings History > 31 > report Date
2017-11-29
Earnings History > 31 > date
2017-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.0075
Earnings History > 31 > eps Estimate
-0.06
Earnings History > 31 > eps Difference
0.0525
Earnings History > 31 > surprise Percent
87.5
Earnings History > 32 > period
2017-06-30
Earnings History > 32 > report Date
2017-09-29
Earnings History > 32 > date
2017-06-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
GBP
Earnings History > 32 > eps Actual
-0.14
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-03-31
Earnings History > 33 > report Date
2017-05-04
Earnings History > 33 > date
2017-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
GBP
Earnings History > 33 > eps Actual
-0.07
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.07
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2016-12-31
Earnings History > 34 > report Date
2017-02-03
Earnings History > 34 > date
2016-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
GBP
Earnings History > 34 > eps Actual
-0.2
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.2
Earnings History > 34 > surprise Percent
-
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer; Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer; and Phase 1 modular clinical trial for patients with advanced solid tumors and lung cancer. The company is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is based in Edinburgh, the United Kingdom.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANuCana Showcases Promising Results for NUC-7738 in Melanoma Treatment TipRanks
Read more →NuCana (NASDAQ: NCNA) reports NUC-7738 activity in PD‑1‑resistant melanoma at ESMO IO Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$104
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.20% of the total shares of NuCana PLC
1.
LUNIS Biotech Growth Opp Fd I a(0.1469%)
since
2024/09/30
2.
Baader Bank INC(0.0259%)
since
2025/06/30
3.
Cetera Investment Advisers(0.0216%)
since
2025/06/30
4.
Glass Jacobson Investment Advisors LLC(0.0039%)
since
2025/06/30
5.
Flagstone Financial Management(0.0033%)
since
2025/06/30
6.
SBI Securities Co Ltd(0.0003%)
since
2025/06/30
7.
AllSquare Wealth Management LLC(0.0001%)
since
2025/06/30
8.
Schonfeld Strategic Advisors LLC(0%)
since
2025/06/30
9.
Susquehanna International Group, LLP(0%)
since
2025/03/31
10.
Tower Research Capital LLC(0%)
since
2025/03/31
11.
Citadel Advisors Llc(0%)
since
2025/03/31
12.
Global Retirement Partners, LLC.(0%)
since
2025/06/30
13.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/03/31
14.
Virtu Financial LLC(0%)
since
2025/03/31
15.
XTX Topco Ltd(0%)
since
2025/06/30
16.
Acadian Asset Management LLC(0%)
since
2025/06/30
17.
Rhumbline Advisers(0%)
since
2025/06/30
18.
Citigroup Inc(0%)
since
2025/06/30
19.
UBS Group AG(0%)
since
2025/06/30
20.
Newbridge Financial Services Group, Inc.(0%)
since
2025/06/30
21.
The Carlyle Group Inc(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-23.31
EPS Estimate
-13
EPS Difference
-10.31
Surprise Percent
-79.3077%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.